New release sharpens adaptive workflow, Elekta Harmony Pro targets busy cancer centers
16.06.2026 - 04:20:41 | ad-hoc-news.deEdited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/15/2026 at 10:18 PM ET. Details in the imprint.
Elekta is expanding its mid-tier linac portfolio with Elekta Harmony Pro, a configuration of its Harmony linear accelerator that puts adaptive radiotherapy workflows and short treatment slots at the center of the design. The system targets clinics that need a compact footprint, fast patient throughput and modern image-guided radiotherapy without stepping up to the most expensive flagship machines. According to Elekta, Harmony Pro is now being marketed as a new release within its Harmony family, combining previously optional capabilities into a standard package for busy cancer centers. Elekta’s official Harmony product page describes the platform as geared toward high productivity in constrained treatment rooms.
What Elekta Harmony Pro is designed to do
Harmony Pro builds on the existing Elekta Harmony linac, which is cleared for clinical use in multiple regions and designed for techniques such as intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and image-guided radiotherapy (IGRT). Elekta positions Harmony as a mid-range system that can deliver precision treatments while fitting into vaults that might be too small for older, bulkier accelerators, helping hospitals upgrade without major construction. The Pro configuration layers on more advanced motion management and image-guidance options, such as fast cone-beam CT and streamlined adaptive workflows, in a bid to close the gap with Elekta’s premium Unity MR-linac at a lower acquisition cost. A recent technical feature in Radiotherapy & Oncology notes that Harmony-class systems are being installed in centers that previously ran older linacs nearing end-of-life, underlining the role of this platform in fleet renewal.
From a hardware standpoint, Harmony Pro retains the single energy linac architecture with a multi-leaf collimator that shapes the radiation beam to the tumor and shields healthy tissue. Elekta highlights that the system can support treatments with typical beam-on times of a few minutes per fraction, which is important for patient comfort and for centers that schedule 40 or more patients per day on a single machine. Workflow software is tightly integrated with Elekta’s Monaco treatment planning system and MOSAIQ oncology information system to minimize manual steps, with standardized protocols intended to reduce variability between therapists. In practical terms, this means a new patient can be imaged, positioned and treated with fewer couch movements and faster imaging, compared with many legacy systems that require separate imaging sessions and longer room occupancy.
On the software side, Harmony Pro is meant to act as a bridge toward adaptive radiotherapy, where treatment plans are adjusted based on changes in patient anatomy over the course of the treatment series. The Pro package is advertised to include more advanced image registration and contouring tools, plus tighter connectivity with Elekta’s cloud-enabled workflow environment. That allows clinics to adopt elements of adaptive therapy - such as frequent plan evaluation and rapid replanning for selected cases - without immediately committing to full online adaptive treatments for every fraction. In a 2025 educational webinar summarized by the European Federation of Organizations for Medical Physics, physicists emphasized that Harmony-era linacs are being deployed as multi-vendor friendly platforms that can work alongside existing imaging and QA systems rather than locking hospitals into a single ecosystem. The EFOMP 2026 summer newsletter reports that Elekta’s latest radiotherapy releases are explicitly described as “multi-vendor by design” and compatible with all Elekta linear accelerators.
Elekta is also framing Harmony Pro as a way to squeeze more performance out of existing bunker space, a practical concern for many hospitals that lack the budget or time to rebuild radiation therapy vaults. The gantry and couch geometry are designed to improve clearance in small rooms, while maintaining the ability to treat from multiple angles and arcs. According to marketing materials, overall system height and required clearance are lower than earlier-generation Elekta linacs, which can simplify installation in facilities with limited ceiling height. That may be particularly relevant in Europe and parts of Asia, where older bunker designs are still common and upgrading to a bulky flagship linac could require costly refurbishment. For US clinics, the promise is more about throughput and staffing: fewer manual steps per treatment can ease pressure on radiation therapists at a time when workforce shortages are a recurring concern.
Pricing for Harmony Pro depends heavily on configuration, service contracts and regional procurement rules, but Elekta has consistently positioned Harmony as more affordable than its Unity MR-linac while still offering advanced techniques required in modern radiotherapy. In market commentary on the global radiotherapy segment, research firms estimate that linacs in this class typically list in a rough range of several million dollars per unit, excluding service and construction. One 2026 report on the radiotherapy equipment market expects the segment to reach about $10.7 billion by 2031, driven in part by replacement of aging linacs in developed markets and first-time installations in emerging regions. An industry press release on the radiotherapy market specifically identifies vendors such as Elekta among the beneficiaries of this replacement and expansion cycle.
Strategically, Harmony Pro sits in the center of Elekta’s radiotherapy portfolio, between entry systems and the high-end Unity platform that integrates MRI with the linac. The company has repeatedly signaled that it sees growth both in premium adaptive solutions and in workhorse linacs that can be deployed in high-volume cancer centers around the world, and Harmony Pro is engineered to serve the latter segment with a modern feature set. While Elekta does not break out revenue by individual product line, linacs are a core part of its Oncology segment, which has historically generated the majority of the group’s sales. Shares of Elekta (ISIN SE0000163628) trade on Nasdaq Stockholm, where the B-share closed at SEK 72.96 on 06/13/2026, according to recent exchange data reported by financial portals such as MarketWatch. MarketWatch’s Elekta quote page shows the stock fluctuating in recent sessions alongside broader healthcare equipment peers.
Elekta Harmony Pro in brief: the hard facts
- Product: Elekta Harmony Pro
- Manufacturer: Elekta AB
- Category: New Release linear accelerator
- Launch date: First marketed as part of the Harmony family in the mid-2020s; Pro configuration promoted as a new release within that platform
- MSRP / Price: Typically several million dollars per system depending on configuration and region; exact list prices vary by market and contract
- Availability: Offered to radiotherapy centers in multiple regions through Elekta’s oncology sales network; subject to local regulatory clearance
- Target audience: High-throughput cancer centers and hospitals needing a compact, modern linac for IMRT, VMAT and IGRT with elements of adaptive workflow
- Key differentiator / USP: Combines a smaller footprint and high patient throughput with integrated image guidance and workflow tools designed for incremental adoption of adaptive radiotherapy
More background on Elekta Harmony
For readers following Elekta’s oncology portfolio, Harmony and Harmony Pro sit alongside the Unity MR-linac and software such as Monaco and MOSAIQ as part of a broader strategy to cover both premium adaptive and high-volume treatment segments.
More Elekta coverage Investor RelationsThis article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.
